Results 71 to 80 of about 29,172 (262)

Recent advances in PLGA polymer nanocarriers for ovarian cancer therapy

open access: yesFrontiers in Oncology
Ovarian cancer (OC) is the most lethal gynecologic malignancy worldwide, and early diagnosis and effective treatment have been the focus of research in this field. It is because of its late diagnosis, acquired resistance mechanisms, and systemic toxicity
Tingjing You, Shengmin Zhang
doaj   +1 more source

Niosome-encapsulated auraptene reduced the mRNA expression of VEGF-A and PDGFs genes in human retina-derived RPE cell line [PDF]

open access: yesInternational Journal of Ophthalmology
AIM: To evaluate the effect of auraptene (AUR) treatment in forms of free and encapsulated in niosome nanoparticles by investigating the mRNA expression level of vascular endothelium growth factor (VEGF)-A and platelet-derived growth factors (PDGFs) in ...
Akram Vahidi   +5 more
doaj   +1 more source

Nanomedicine Meets Immunotherapy: Advancing Adoptive Cell Therapy with Nanoparticles in the Treatment of Cancer with Sustainability Perspectives

open access: yesAdvanced Science, EarlyView.
This review surveys nanoparticle‐based strategies to enhance adoptive cell therapy, particularly CAR‐T cell approaches, in solid tumor treatment. It describes how nanoparticles can improve tumor immunogenicity and T‐cell infiltration while reducing toxicity, and how they enable in vivo CAR‐T cell generation.
Erica Frostegård   +19 more
wiley   +1 more source

A Simple Route to the Complexation of Lutein with Reduced Graphene Oxide Nanocarriers and Antioxidant Protection Against Blue Light

open access: yesInternational Journal of Nanomedicine, 2021
Seon Yeong Chae,1 Min Chan Shin,2 Sangheon Jeon,2 Moon Sung Kang,2 Dong-Wook Han,2 Suck Won Hong2 1Research Center for Dielectric and Advanced Matter Physics, Pusan National University, Busan, 46241, Republic of Korea; 2Department of Cogno-Mechatronics ...
Chae SY   +5 more
doaj  

Nanoantioxidants: Recent Trends in Antioxidant Delivery Applications

open access: yesAntioxidants, 2019
Antioxidants interact with free radicals, terminating the adverse chain reactions and converting them to harmless products. Antioxidants thus minimize the oxidative stress and play a crucial role in the treatment of free radicals-induced diseases ...
Ibrahim Khalil   +7 more
doaj   +1 more source

TME/NIR Dual‐Responsive Zinc‐Based Targeted Nanoagonist for Multimodal Amplification of STING‐Mediated Cancer Immunotherapy

open access: yesAdvanced Science, EarlyView.
A multifunctional nanoagonist (cDZ@IP) enables nano‐metabolite–driven multimodal activation of the STING pathway and enhanced immune recognition, achieving potent antitumor immunity and suppressing tumor growth and metastasis. This strategy highlights the rational design of therapeutic metabolites and establishes a new paradigm bridging nanomedicine ...
Kepeng Hu   +17 more
wiley   +1 more source

Harnessing nanotechnology for enhanced epilepsy management

open access: yesMGM Journal of Medical Sciences
Epilepsy, a condition characterized by unprovoked, recurrent seizures, currently has no cure, with treatments ranging from medications to treatment modalities such as antiepileptic drugs (AEDs) and vagus nerve stimulation, as well as ketogenic diet and ...
V. Manasa   +5 more
doaj   +1 more source

Low-frequency transcranial magnetic stimulation is beneficial for enhancing synaptic plasticity in the aging brain

open access: yesNeural Regeneration Research, 2015
In the aging brain, cognitive function gradually declines and causes a progressive reduction in the structural and functional plasticity of the hippocampus. Transcranial magnetic stimulation is an emerging and novel neurological and psychiatric tool used
Zhan-chi Zhang   +5 more
doaj   +1 more source

Transdermal Nanocarriers [PDF]

open access: yes, 2010
This chapter aims to show state-of-the-art transd ermal drug-delivery nanocarriers. The advances in this field are very important at present because the skin offe rs many advantages over othe r organs due to its size. Depending on the location, we can deliver drugs very close to the target area.
openaire   +1 more source

Brain and Liver Dual‐Targeting Oridonin Nanoparticles to Enhance Aβ Clearance for Alzheimer's Disease Therapy

open access: yesAdvanced Science, EarlyView.
We developed a nanoparticle named OAF, which simultaneously targeted to both the brain and liver via the transferrin receptor 1 (TfR1) receptor, promoting lipoprotein receptor‐related protein 1 (LRP1) expression to enhance amyloid‐beta (Aβ) clearance. In AD mice model, OAF significantly reduced Aβ deposition and cognitive impairment, while a mitigating
Wenshuai Gong   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy